sponsored
PatientsVille.com Logo

PatientsVille

Somatropin Neoplasm Recurrence Side Effects

Somatropin Neoplasm Recurrence Side Effect Reports


The following Somatropin Neoplasm Recurrence side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Neoplasm Recurrence, can occur, and what you can do about them.

A side effect could appear soon after you start Somatropin or it might take time to develop.



Meningioma, Neoplasm Recurrence

This Neoplasm Recurrence side effect was reported by a physician from FRANCE. A 23-year-old patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Somatropin (dosage: Unk), which was started on Sep 02, 2002. Concurrently used drugs: NA. When starting to take Somatropin the consumer reported the following symptoms:
  • Meningioma
  • Neoplasm Recurrence
These side effects may potentially be related to Somatropin.
Craniopharyngioma, Neoplasm Recurrence

This Neoplasm Recurrence Somatropin side effect was reported by a physician from JAPAN on Jun 08, 2012. A male , child 11 years of age, was treated with Somatropin. The patient presented the following health conditions:
  • Craniopharyngioma
  • Neoplasm Recurrence
. Somatropin dosage: 0.8 Mg, 1x/day. Additional drugs used at the same time: NA. The patient was hospitalized.
Neoplasm Recurrence, Craniopharyngioma

This is a Somatropin side effect report of a 11-year-old patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Somatropin (dosage:0.8 Mg, 1x/day, start time: Jul 16, 2009), combined with:
  • Gonadotropin Chorionic (900 Iu, Monthly)
, and developed a serious reaction and a Neoplasm Recurrence side effect. The patient presented with:
  • Neoplasm Recurrence
  • Craniopharyngioma
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatropin treatment in patients suffering from NA, resulting in Neoplasm Recurrence.

Meningioma, Neoplasm Recurrence

A 23-year-old patient (weight: NA) from FRANCE with the following symptoms: NA started Somatropin treatment (dosage: Unk) on Sep 02, 2002. Soon after starting Somatropin treatment, the consumer experienced several side effects, including:
  • Meningioma
  • Neoplasm Recurrence
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Somatropin side effects, such as Neoplasm Recurrence.
Craniopharyngioma, Neoplasm Recurrence

A patient from JAPAN was prescribed and started Somatropin on Apr 19, 2012. Patient felt the following Somatropin side effects: craniopharyngioma, neoplasm recurrence Additional patient health information: male , child 11 years of age, The consumer reported the following symptoms: . Somatropin dosage: 0.8 Mg, 1x/day. Concurrently used drugs: NA. The patient was hospitalized.
Craniopharyngioma, Neoplasm Recurrence

This report suggests a potential Somatropin Neoplasm Recurrence side effect(s) that can have serious consequences. A 22-year-old patient from SPAIN (weight:NA) was diagnosed with the following health condition(s): growth hormone deficiency,blood antidiuretic hormone decreased,blood luteinising hormone decreased,primary hypothyroidism,blood corticotrophin decreased,blood thyroid stimulating hormone decreased,blood follicle stimulating hormone decreased,hypogonadism and used Somatropin (dosage: 1 Mg, Daily) starting Jan 24, 2008. Soon after starting Somatropin the patient began experiencing various side effects, including:
  • Craniopharyngioma
  • Neoplasm Recurrence
Drugs used concurrently:
  • Desmopressin (Unk)
  • Testosterone
  • Thyroxine ^aps^ (Unk)
  • Hidroaltesona (Unk)
  • Thyroxine ^aps^
  • Testosterone (Unk)
  • Testosterone
The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Neoplasm Recurrence, may still occur.
Craniopharyngioma, Neoplasm Recurrence

An adverse event was reported by a physician on Nov 08, 2011 by a male taking Somatropin Rdna (dosage: 0.2 Mg, 1x/day) was diagnosed with and. Location: SLOVAKIA (Slovak Republic) , 35 years of age, weighting 286.6 lb, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Somatropin side effects: craniopharyngioma, neoplasm recurrence. Additional medications/treatments: The patient was hospitalized.
Pituitary Tumour Benign, Neoplasm Recurrence

This Neoplasm Recurrence problem was reported by a physician from SLOVAKIA (Slovak Republic). A 23-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): hypopituitarism.On Aug 12, 2005 a consumer started treatment with Somatropin (dosage: 0.7 Mg, 1x/day). The following drugs/medications were being taken at the same time:
  • Parlodel
  • Levothyroxine Sodium
  • Cortef
  • Klimonorm
When commencing Somatropin, the patient experienced the following unwanted symptoms /side effects:
  • Pituitary Tumour Benign
  • Neoplasm Recurrence
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Neoplasm Recurrence, may become evident only after a product is in use by the general population.
Craniopharyngioma, Neoplasm Recurrence

This is a Somatropin side effect report of a 13-year-old patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hypopituitarism and was treated with Somatropin (dosage: 0.8 Mg, 1x/day) starting Nov 15, 2004. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Craniopharyngioma
  • Neoplasm Recurrence
The patient was hospitalized. This opens a possibility that Somatropin could cause Neoplasm Recurrence and that some patients may be more susceptible.
Neoplasm Recurrence, Craniopharyngioma

This Neoplasm Recurrence side effect was reported by a physician from JAPAN on Apr 28, 2011. A patient from JAPAN , child 10 years of age, was diagnosed with and was treated with Somatropin. Directly after treatment started, patient experienced the unwanted or unexpected Somatropin side effects: neoplasm recurrence, craniopharyngioma. Somatropin dosage: 0.025 Mg/kg/day. These side effects may potentially be related to Somatropin.
Neoplasm Recurrence, Craniopharyngioma

This Neoplasm Recurrence side effect was reported by a physician from JAPAN. A 10-year-old patient (weight:NA) experienced the following symptoms/conditions: growth hormone deficiency. The patient was prescribed Somatropin (dosage: 0.025 Mg/kg/day), which was started on NS. Concurrently used drugs: NA. When starting to take Somatropin the consumer reported the following symptoms:
  • Neoplasm Recurrence
  • Craniopharyngioma
These side effects may potentially be related to Somatropin.
Neoplasm Recurrence, Meningioma

This Neoplasm Recurrence Somatropin side effect was reported by a physician from FRANCE on Jan 31, 2011. A Female , 50 years of age, was treated with Somatropin. The patient presented the following health conditions:
  • Neoplasm Recurrence
  • Meningioma
. Somatropin dosage: 0.3 Mg, 1x/day. Additional drugs used at the same time:
  • Utrogestan (Unk)
  • Estreva (Unk)
The patient was hospitalized.
Craniopharyngioma, Neoplasm Recurrence

This is a Somatropin side effect report of a 45-year-old female patient (weight:NA) from GERMANY, suffering from the following symptoms/conditions: hypopituitarism, who was treated with Somatropin (dosage:0.2 Mg, 1x/day, start time: Sep 01, 2008), combined with: NA., and developed a serious reaction and a Neoplasm Recurrence side effect. The patient presented with:
  • Craniopharyngioma
  • Neoplasm Recurrence
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatropin treatment in female patients suffering from hypopituitarism, resulting in Neoplasm Recurrence.
Craniopharyngioma, Neoplasm Recurrence

A 45-year-old female patient (weight: NA) from GERMANY with the following symptoms: hypopituitarism started Somatropin treatment (dosage: 0.1 Mg, 1x/day) on Sep 01, 2008. Soon after starting Somatropin treatment, the consumer experienced several side effects, including:
  • Craniopharyngioma
  • Neoplasm Recurrence
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Somatropin side effects, such as Neoplasm Recurrence.
Neoplasm Recurrence, Oligodendroglioma

A patient from UNITED KINGDOM was prescribed and started Somatropin on Jul 29, 2010. After Somatropin was administered, patient encountered several Somatropin side effects: neoplasm recurrence, oligodendroglioma Additional patient health information: Patient , 46 years of age, weighting 216.1 lb, The consumer reported the following symptoms: was diagnosed with and. Somatropin dosage: 0.3 Mg, 1x/day. Concurrently used drugs: NA. The patient was hospitalized.
Neoplasm Recurrence, Oligodendroglioma

This report suggests a potential Somatropin Neoplasm Recurrence side effect(s) that can have serious consequences. A 46-year-old patient from UNITED KINGDOM (weight:NA) was diagnosed with the following health condition(s): hypopituitarism and used Somatropin (dosage: 0.3 Mg, 1x/day) starting Oct 26, 2006. Soon after starting Somatropin the patient began experiencing various side effects, including:
  • Neoplasm Recurrence
  • Oligodendroglioma
Drugs used concurrently:NA. The patient was hospitalized. Although Somatropin demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Neoplasm Recurrence, may still occur.
Brain Stem Glioma, Neoplasm Recurrence

An adverse event was reported by a physician on Jul 02, 2010 by a male taking Somatropin (dosage: 1.2 Mg, 1x/day) was diagnosed with and. Location: SPAIN , child 10 years of age, weighting 105.8 lb, patient began experiencing various side effects, including: Patient felt the following Somatropin side effects: brain stem glioma, neoplasm recurrence. Additional medications/treatments: The patient was hospitalized and became disabled.
Craniopharyngioma, Neoplasm Recurrence

This Neoplasm Recurrence problem was reported by a physician from JAPAN. A patient (weight: NA) was diagnosed with the following medical condition(s): hypopituitarism.On Mar 12, 2009 a consumer started treatment with Somatropin (dosage: 0.8 Mg, 1x/day). The following drugs/medications were being taken at the same time: NA. When commencing Somatropin, the patient experienced the following unwanted symptoms /side effects:
  • Craniopharyngioma
  • Neoplasm Recurrence
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Neoplasm Recurrence, may become evident only after a product is in use by the general population.
Craniopharyngioma, Neoplasm Recurrence

This is a Somatropin side effect report of a 45-year-old female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: hypopituitarism and was treated with Somatropin (dosage: 0.2 Mg, 1x/day) starting Mar 16, 2009. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Craniopharyngioma
  • Neoplasm Recurrence
This opens a possibility that Somatropin could cause Neoplasm Recurrence and that some female patients may be more susceptible.
Craniopharyngioma, Neoplasm Recurrence

This Neoplasm Recurrence side effect was reported by a health professional from UNITED STATES on Apr 02, 2010. A patient from UNITED STATES , weighting 59.52 lb, was diagnosed with and was treated with Somatropin. Patient felt the following Somatropin side effects: craniopharyngioma, neoplasm recurrence. Somatropin dosage: 0.7 Mg, 1x/day.
Multiple prescriptions taken:
  • Levoxyl
  • Cortef
  • Ddavp
The patient was hospitalized. These side effects may potentially be related to Somatropin.
1 of 2 

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Somatropin Neoplasm Recurrence Causes and Reviews


Breast cancer affects one in eight women during their lives. No one knows why some women get breast cancer, but there are many risk factors. Risks that you cannot change include

  • Age - the risk rises as you get older
  • Genes - two genes, BRCA1 and BRCA2, greatly increase the risk. Women who have family members with breast or ovarian cancer may wish to be tested for the genes.
  • Personal factors - beginning periods before age 12 or going through menopause after age 55

Other risks include obesity, using hormone replacement therapy (also called menopausal hormone therapy), taking birth control pills, drinking alcohol, not having children or having your first child after age 35, and having dense breasts.

Symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast, and discharge from a nipple. Breast self-exams and mammography can help find breast cancer early, when it is most treatable. One possible treatment is surgery. It could be a lumpectomy or a mastectomy. Other treatments include radiation therapy, chemotherapy, hormone therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

Men can have breast cancer, too, but it is rare.

NIH: National Cancer Institute


Somatropin Neoplasm Recurrence Reviews

Fri, 24 Feb 2012

My 19 year old son tried to give blood the other day and he was refused because he answered the question that he had taken HGH, Somatropin under a doctor's care.  He asked why and they said it had been shown to cause birth defects.  I am trying to find information on that but I am not being successful.
He took the drugs for about 5 years 12-17.  As we look to the future and him possibly having children is this something we need to be concerned about or aware of?  We are in the process of contacting the doctor who prescribed the meds to get his input.

Tue, 19 Jul 2011

Why do people die after starting Growth Hormone treatment?

Fri, 08 Jul 2011

Sorry about my poor medical english.
I am counselling as a lawyer a young man suffering from liposarcoma, we believe related to Saizen that he received during his childhood.Saizen was the french commercial name for Somatropin.
Has anyone got info on the related risk of cancer?
I would very much appreciate any help to links or info.

Mon, 19 Oct 2009
at what age will be recomended to use HGH for athlete of high level of competence..
Tue, 11 Jan 2011
I've been on it for 9 months. I weighed at the beginning 125 and had a body fat of 24. I now weigh 130 I have the same body fat percentage. While I have increased muscle mass, I eat well work out, have increased cardio amp; workouts, I'm sad that the only way that I can decrease my body fat is to eat less amp; be hungry always. So of course I can get leaner but cannot stay there. Too painful. It has increased my recovery time from workouts but I'm thinking of going off of it since I am able to control my weight the same as with it or without it.. I am wondering if others do not get leaned out on his product.. I started it because I was so deficient that I had to recover for weeks most time between workouts and had trouble functioning in my. Life. So that is superior now. I thought it would help with fat loss but it does not for me
Sat, 09 Jul 2011
hi i need information toward Somatropin label price?
DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Somatropin Side Effects

Craniopharyngioma (59)
Death (54)
Pituitary Tumour Benign (45)
Neoplasm Recurrence (43)
Condition Aggravated (42)
Sleep Apnoea Syndrome (41)
Adenoidal Hypertrophy (33)
Meningioma (29)
Tonsillar Hypertrophy (28)
Headache (27)
Prostate Cancer (23)
Dyspnoea (22)
Germ Cell Cancer (20)
Fall (20)
Scoliosis (19)
Convulsion (18)
Pneumonia (18)
Vomiting (18)
Disease Progression (17)
Osteochondrosis (16)
Abdominal Pain (15)
Osteonecrosis (15)
Brain Neoplasm (15)
Neoplasm Progression (15)
Fatigue (14)
Diabetes Mellitus (14)
Arthralgia (14)
Cardiac Arrest (14)
Asthenia (13)
Astrocytoma (12)
Cerebrovascular Accident (12)
Hypertension (12)
Papillary Thyroid Cancer (12)
Nausea (12)
Fracture (11)
Dysphonia (11)
Epiphysiolysis (11)
Hemiparesis (11)
Tachyarrhythmia (11)
Sudden Death (11)
Laryngocele (10)
Hepatic Function Abnormal (10)
Brain Neoplasm Malignant (10)
Medulloblastoma Recurrent (10)
Gastroenteritis (10)
Renal Cell Carcinoma (10)
Stridor (10)
Somnolence (10)
Respiratory Distress (10)
Pituitary Tumour Recurrent (10)

➢ More

Discuss Somatropin Side Effects